357 related articles for article (PubMed ID: 21901234)
1. The role of fibrinogen plasma levels, the -455G>A fibrinogen and the factor XIII A subunit (FXIII-A) Val34Leu polymorphism in cancer-associated venous thrombosis.
Tiedje V; Dunkler D; Ay C; Horvath B; Quehenberger P; Pabinger M; Zielinski C; Pabinger I; Mannhalter C
Thromb Haemost; 2011 Nov; 106(5):908-13. PubMed ID: 21901234
[TBL] [Abstract][Full Text] [Related]
2. Fibrinogen Aalpha-Thr312Ala and factor XIII-A Val34Leu polymorphisms in idiopathic venous thromboembolism.
Le Gal G; Delahousse B; Lacut K; Malaviolle V; Regina S; Blouch MT; Couturaud F; Mottier D; Oger E; Gruel Y;
Thromb Res; 2007; 121(3):333-8. PubMed ID: 17568659
[TBL] [Abstract][Full Text] [Related]
3. D-dimer and prothrombin fragment 1 + 2 predict venous thromboembolism in patients with cancer: results from the Vienna Cancer and Thrombosis Study.
Ay C; Vormittag R; Dunkler D; Simanek R; Chiriac AL; Drach J; Quehenberger P; Wagner O; Zielinski C; Pabinger I
J Clin Oncol; 2009 Sep; 27(25):4124-9. PubMed ID: 19636003
[TBL] [Abstract][Full Text] [Related]
4. Factor XIII-A subunit Val34Leu polymorphism is associated with the risk of thrombosis in patients with antiphospholipid antibodies and high fibrinogen levels.
de la Red G; Tàssies D; Espinosa G; Monteagudo J; Bové A; Plaza J; Cervera R; Reverter JC
Thromb Haemost; 2009 Feb; 101(2):312-6. PubMed ID: 19190815
[TBL] [Abstract][Full Text] [Related]
5. Factor XIII Val34Leu polymorphism modulates the prothrombotic and inflammatory state associated with atrial fibrillation.
Marín F; Corral J; Roldán V; González-Conejero R; del Rey ML; Sogorb F; Lip GY; Vicente V
J Mol Cell Cardiol; 2004 Sep; 37(3):699-704. PubMed ID: 15350843
[TBL] [Abstract][Full Text] [Related]
6. Association of genetic variants of hemostatic genes with myocardial infarction in Egyptian patients.
El-Fattah AAA; Sadik NAH; Sedrak H; Battah A; Nabil M
Gene; 2018 Jan; 641():212-219. PubMed ID: 29054763
[TBL] [Abstract][Full Text] [Related]
7. Factor XIII Val34Leu variant is protective against venous thromboembolism: a HuGE review and meta-analysis.
Wells PS; Anderson JL; Scarvelis DK; Doucette SP; Gagnon F
Am J Epidemiol; 2006 Jul; 164(2):101-9. PubMed ID: 16740590
[TBL] [Abstract][Full Text] [Related]
8. The genetics of venous thromboembolism. A meta-analysis involving approximately 120,000 cases and 180,000 controls.
Gohil R; Peck G; Sharma P
Thromb Haemost; 2009 Aug; 102(2):360-70. PubMed ID: 19652888
[TBL] [Abstract][Full Text] [Related]
9. [Factor XIII-A subunit Val34Leu polymorphism and risk of venous thromboembolism in young adults].
Demyanenko AV; Kapustin SI; Soroka VV; Chechulov PV
Angiol Sosud Khir; 2015; 21(2):21-5. PubMed ID: 26035561
[TBL] [Abstract][Full Text] [Related]
10. Decreased factor XIII levels in factor XIII A subunit Leu34 homozygous patients with coronary artery disease.
Bereczky Z; Balogh E; Katona E; Czuriga I; Kárpáti L; Shemirani AH; Edes I; Muszbek L
Thromb Res; 2008; 121(4):469-76. PubMed ID: 17597187
[TBL] [Abstract][Full Text] [Related]
11. Factor XIII Val34Leu polymorphism and the risk of myocardial infarction under the age of 36 years.
Rallidis LS; Politou M; Komporozos C; Panagiotakos DB; Belessi CI; Travlou A; Lekakis J; Kremastinos DT
Thromb Haemost; 2008 Jun; 99(6):1085-9. PubMed ID: 18521512
[TBL] [Abstract][Full Text] [Related]
12. Factor XIII levels and factor XIII B subunit polymorphisms in patients with venous thromboembolism.
Mezei ZA; Katona É; Kállai J; Bereczky Z; Somodi L; Molnár É; Kovács B; Miklós T; Ajzner É; Muszbek L
Thromb Res; 2017 Oct; 158():93-97. PubMed ID: 28865246
[TBL] [Abstract][Full Text] [Related]
13. Modulation of the risk of coronary sclerosis/myocardial infarction by the interaction between factor XIII subunit A Val34Leu polymorphism and fibrinogen concentration in the high risk Hungarian population.
Bereczky Z; Balogh E; Katona E; Pocsai Z; Czuriga I; Széles G; Kárpáti L; Adány R; Edes I; Muszbek L
Thromb Res; 2007; 120(4):567-73. PubMed ID: 17250879
[TBL] [Abstract][Full Text] [Related]
14. FXIII polymorphisms, fibrin clot structure and thrombotic risk.
Kobbervig C; Williams E
Biophys Chem; 2004 Dec; 112(2-3):223-8. PubMed ID: 15572253
[TBL] [Abstract][Full Text] [Related]
15. Factor XIII, clot structure, thrombosis.
Bagoly Z; Koncz Z; Hársfalvi J; Muszbek L
Thromb Res; 2012 Mar; 129(3):382-7. PubMed ID: 22197181
[TBL] [Abstract][Full Text] [Related]
16. Genetic association between FXIII and β-fibrinogen genes and women with recurrent spontaneous abortion: a meta- analysis.
Li J; Wu H; Chen Y; Wu H; Xu H; Li L
J Assist Reprod Genet; 2015 May; 32(5):817-25. PubMed ID: 25862345
[TBL] [Abstract][Full Text] [Related]
17. Single nucleotide polymorphisms in inflammation-related genes are associated with venous thromboembolism.
Beckers MM; Ruven HJ; Haas FJ; Doevendans PA; ten Cate H; Prins MH; Biesma DH
Eur J Intern Med; 2010 Aug; 21(4):289-92. PubMed ID: 20603037
[TBL] [Abstract][Full Text] [Related]
18. A common mutation in the gene for coagulation factor XIII-A (VAL34Leu): a risk factor for primary intracerebral hemorrhage is protective against atherothrombotic diseases.
Gemmati D; Serino ML; Ongaro A; Tognazzo S; Moratelli S; Resca R; Moretti M; Scapoli GL
Am J Hematol; 2001 Jul; 67(3):183-8. PubMed ID: 11391716
[TBL] [Abstract][Full Text] [Related]
19. High factor VIII levels independently predict venous thromboembolism in cancer patients: the cancer and thrombosis study.
Vormittag R; Simanek R; Ay C; Dunkler D; Quehenberger P; Marosi C; Zielinski C; Pabinger I
Arterioscler Thromb Vasc Biol; 2009 Dec; 29(12):2176-81. PubMed ID: 19778945
[TBL] [Abstract][Full Text] [Related]
20. Factor XIII Val34Leu is a genetic factor involved in the etiology of venous thrombosis.
Franco RF; Reitsma PH; Lourenço D; Maffei FH; Morelli V; Tavella MH; Araújo AG; Piccinato CE; Zago MA
Thromb Haemost; 1999 May; 81(5):676-9. PubMed ID: 10365735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
